IL-6 signaling and breast cancer
US10481159B2 · kind B2 · utility
2Cited by
0References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 8, 2017 |
| Grant date | Nov 19, 2019 |
| Priority date | — |
| Expiry date | Nov 8, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/54
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The disclosure provides, inter alia, methods of detecting IL-6 signaling activity in T cells in breast cancer patients, such as breast cancer patients in remission.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.